- AuthorisedTherapeutic confirmatory (Phase III)
A Phase 3, Multicenter, Open Label, Basket, Long-term Extension Study of Icotrokinra in Pediatric Clinical Study Participants
This study looks at a new medicine called icotrokinra for children and young people with immune system conditions. It is an extension study, meaning it offers ongoing treatment to young patients who finished an earlier trial, helping doctors learn about the medicine's long-term safety, effects, and benefits.
For: Immune System DisordersHungary · Spain · Germany - RecruitingPhase III
A Study of Icotrokinra in participants with moderately to severely active Crohn's disease
This study tests a new medicine called icotrokinra for Crohn's disease. Researchers want to see if it helps reduce inflammation better than a dummy treatment. It involves different doses and close monitoring over several years for people with moderate to severe Crohn's.
For: Moderate to Severe Crohn's disease, Plaque psoriasisUnited Kingdom · England · Scotland - Active not recruitingPHASE3
A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
This study is looking at a new medication, JNJ-77242113, for people with moderate to severe plaque psoriasis. It compares the new medication to a widely used treatment (ustekinumab) and a dummy medicine (placebo) to see how safe and effective it is.
For: Plaque PsoriasisUnited States · Argentina · Australia - Active not recruitingPHASE3
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
This study is looking at a new medicine, JNJ-77242113, for people with moderate to severe plaque psoriasis. It compares how well it works against a dummy treatment (placebo) and an existing medicine called deucravacitinib.
For: Plaque PsoriasisUnited States · Argentina · Australia - Active not recruitingPHASE3
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
This study is testing a new medicine called JNJ-77242113 for people with moderate to severe plaque psoriasis. Researchers want to see if it works better than a dummy treatment or another existing medicine.
For: Plaque PsoriasisUnited States · Australia · Brazil - Active not recruitingPHASE3
A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)
This study is looking at a new medicine, JNJ-77242113, for people with plaque psoriasis on sensitive areas like the scalp, genitals, or palms and soles. It aims to see if this medicine works better than a dummy treatment.
For: Plaque PsoriasisUnited States · Argentina · Canada - Active not recruitingPHASE3
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
This study is looking into a new treatment called JNJ-77242113 for moderate to severe plaque psoriasis in teenagers and adults. We want to see how well it works to improve skin symptoms. It's a Phase 3 trial, meaning it's a key step in testing this potential new medicine.
For: Plaque PsoriasisUnited States · Argentina · Australia